RedHill Biopharma (RDHL) Total Liabilities (2011 - 2025)
RedHill Biopharma (RDHL) posted quarterly Total Liabilities of $21.1 million for Q4 2025, down 7.26% year-over-year from $22.7 million in Q4 2024, and down 7.5% quarter-over-quarter from $22.8 million in Q2 2025.
RedHill Biopharma (RDHL) Total Liabilities (2011 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Total Liabilities for 15 consecutive years, with $21.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Liabilities fell 7.26% year-over-year to $21.1 million; the TTM figure through Dec 2025 stood at $21.1 million (down 7.26% YoY), while the FY2025 annual figure was $21.1 million, down 7.26% from the prior year.
- Total Liabilities eased to $21.1 million in Q4 2025 per RDHL's latest filing, from $22.8 million in the prior quarter.
- Across five years, Total Liabilities topped out at $203.2 million in Q3 2022 and bottomed at $741000.0 in Q4 2023.
- Historically, Total Liabilities has averaged $91.6 million across 5 years, with a median of $56.8 million in 2023.
- Annual changes were most pronounced in 2023 — Total Liabilities plunged 99.09% — and 2024, when it jumped 2966.94%.
- RedHill Biopharma's Total Liabilities stood at $172.3 million in 2021, then tumbled by 98.48% to $2.6 million in 2022, then sank by 71.75% to $741000.0 in 2023, then surged by 2966.94% to $22.7 million in 2024, then slipped by 7.26% to $21.1 million in 2025.
- Business Quant data shows RDHL's Total Liabilities at $21.1 million in Q4 2025, $22.8 million in Q2 2025, and $22.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 2.12 Bn |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | 21.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.08 Mn |
| Jun 30, 2025 | 22.79 Mn |
| Dec 31, 2024 | 22.73 Mn |
| Jun 30, 2024 | 2.54 Mn |
| Dec 31, 2023 | 741,000.00 |
| Jun 30, 2023 | 1.64 Mn |
| Mar 31, 2023 | 56.83 Mn |
| Dec 31, 2022 | 2.62 Mn |
| Sep 30, 2022 | 203.22 Mn |
| Jun 30, 2022 | 179.91 Mn |
| Mar 31, 2022 | 172.29 Mn |
| Dec 31, 2021 | 172.31 Mn |
| Sep 30, 2021 | 174.79 Mn |
| Jun 30, 2021 | 174.09 Mn |
| Mar 31, 2021 | 167.08 Mn |
| Dec 31, 2020 | 166.38 Mn |
| Sep 30, 2020 | 140.24 Mn |
| Jun 30, 2020 | 131.78 Mn |
| Mar 31, 2020 | 99.83 Mn |
| Dec 31, 2019 | 14.10 Mn |